Nasus Pharma Ltd. (NSRX): Kewajiban utang agregat

Demand for antiviral protection is independent of GDP, meaning total loans and credits demonstrate asset stability. An innovative nasal ecosystem creates barriers for competitors, while a compact staff of experts optimizes expenses. The value of 0.00 serves as the current parameter value, capturing the current debt load of Nasus Pharma Ltd (NSRX) on the chart.

The market assesses the potential of Nasus Pharma Ltd (NSRX) through its debt balance, which measures the aggregate of all debt obligations to analyze financial stability and expansion rates. By examining the history of debt volume, an investor can understand how credit resources fund the implementation of unique powder nasal delivery systems, which defines the company's status as a growth asset in the biopharmaceutical sector.